<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000711867"><TermName>R-CVP regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat indolent (slow-growing) non-Hodgkin lymphoma. It includes the drugs rituximab, cyclophosphamide, vincristine sulfate, and prednisone. Also called R-CVP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000733051" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;R-CVP regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000733052" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen R-CVP&quot;" language="es" id="_4"/><SpanishTermName>régimen R-CVP</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de una quimioterapia combinada que se usa para tratar el linfoma no Hodgkin indolente (de crecimiento lento). Incluye los medicamentos rituximab, ciclofosfamida, sulfato de vincristina y prednisona. También se llama R-CVP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2011-09-15</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000710824">R-CVP</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
